课题基金 / 基金详情

Mitochondrial and Metabolic Dysfunction in Age-related Neurodegeneration

Mitochondrial and Metabolic Dysfunction in Age-related Neurodegeneration
年龄相关神经变性中的线粒体和代谢功能障碍
批准号:
9926781
负责人:
GARY E GIBSON
金额:
$242.06万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2022-03-31
关键词:
AcetylationAcetylcholineAddressAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAmyloid depositionAstrocytesAutophagocytosisAutopsyBiogenesisBiologyBrainCell LineCell NucleusCell RespirationCellsCitric Acid CycleCognitionCouplingCultured CellsCytosolDeacetylaseDeoxyglucoseDevelopmentDiseaseElectron TransportEnergy MetabolismEpigenetic ProcessGene AbnormalityGene ActivationGene ExpressionGene-ModifiedGenesGenetic TranscriptionGlucoseGlycolysisGoalsHexosaminesHumanImpaired cognitionImpairmentIndividualLeadLearningLinkMagnetic Resonance ImagingMeasuresMemoryMemory impairmentMetabolicMetabolic dysfunctionMetabolismMethylationMitochondriaModelingMonitorMusNADHNADPNerve DegenerationNeurodegenerative DisordersNeurofibrillary TanglesNeuronsNeurotransmittersOxidative StressOxygenOxygen ConsumptionPathologyPathway interactionsPentosephosphate PathwayPeroxisome Proliferator-Activated ReceptorsPost-Translational Protein ProcessingPre-Clinical ModelProcessProductionProteinsProteomeReporterRepressionResearchRodentRoleSignal TransductionSirtuinsSliceTauopathiesTestingTherapeuticTherapeutic InterventionTimeTransgenic OrganismsTreatment Efficacyage related neurodegenerationbasecognitive changeeffective therapyexperimental studyglucose metabolismin vitro Modelin vivoin vivo bioluminescence imaginginduced pluripotent stem cellinnovationinsightmicroPETmitochondrial dysfunctionmitochondrial metabolismmouse modelneurodegenerative dementianeurofibrillary tangle formationnovelnovel strategiesnovel therapeutic interventionnovel therapeuticsprogramsprotein expressionpublic health relevanceresponsetherapeutic developmenttherapeutic targettranscription factor

项目摘要

项目成果

GARY E GIBSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Age-related neurodegenerative diseases including Alzheimer's Disease (AD) are associated with mild impairment of oxidative metabolism, oxidative stress and accumulation of abnormal proteins. Diminished glucose metabolism and abnormal mitochondrial function are invariant features of AD. The changes occur early in the disease and can be plausibly linked to the pathology including the plaques, tangles and memory deficits. Our previous studies proved our underlying hypothesis that "mitochondrial dysfunction in age-related neurodegenerative diseases promotes the development of disease and impairs the ability of the brain to adapt". The current program project will test the underlying mechanism for those changes, and test multiple approaches for reversing the deficits. The underlying hypothesis for this proposal is that posttranslational modifications and transcription for key proteins of energy metabolism as well as plasticity genes are abnormal in AD and form effective therapeutic targets. Protein modifications that are sensitive to metabolic state including acetylation, methylation and succinylation may alter protein interactions in the mitochondria as well as the ability of proteins to modulate transcription. Activation of genes PGC-1alpha, NRF2/ARE that stimulate biogenesis and the relationship to selective sirtuins (NAD-dependent deacetylases) will be tested in mouse models of AD as well as cultured cells from humans and rodents. The cross talk of mitochondria with the nucleus and cytosol may promote fission, fusion, mitophagy or autophagy and alter transcription of TCA cycle genes. Changes in the expression of the proteins modulating the mitochondrial proteome composition may affect the energy metabolism and the contribution of mitochondria to oxidative stress. The plasticity genes and the modification of their transcription by acetylation and methylation directly link metabolism and transcription and plasticity. The reversible repression of plasticity associated gene expression and diminished learning and memory provide a mechanism for AD related changes and their reversal. Successful completion of the goals of these projects can be expected to provide new insights into neurodegenerative processes and contribute to novel approaches to ameliorating age-related neurodegeneration.
期刊论文(130)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1523/jneurosci.6303-11.2012
发表时间: 2012-02-29
期刊: The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子: --
作者: [Niatsetskaya ZV, Sosunov SA, Matsiukevich D, Utkina-Sosunova IV, Ratner VI, Starkov AA, Ten VS]
通讯作者: Ten VS
DOI: 10.1002/jnr.24103
发表时间: 2017-11
期刊: Journal of neuroscience research
影响因子: 4.2
作者: [Chen H, Xu H, Potash S, Starkov A, Belousov VV, Bilan DS, Denton TT, Gibson GE]
通讯作者: Gibson GE
Measurement of mitochondrial ROS production.
线粒体ROS产生的测量。
DOI: 10.1007/978-1-60761-756-3_16
发表时间: 2010
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Starkov, Anatoly A]
通讯作者: Starkov, Anatoly A
DOI: 10.1016/j.neuron.2010.07.011
发表时间: 2010-07-29
期刊: NEURON
影响因子: 16.2
作者: [Johri, Ashu, Beal, M. Flint]
通讯作者: Beal, M. Flint
73
    Benfotiamine in Alzheimer's Disease: A pilot study
    Benfotiamine in Alzheimer's Disease: A pilot study
    Benfotiamine in Alzheimer's Disease: A pilot study
    Benfotiamine in Alzheimer's Disease: A pilot study
    海外基金